Elsevier, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 12(1833), p. 3375-3385, 2013
DOI: 10.1016/j.bbamcr.2013.09.018
Full text: Unavailable
Excessive generation of reactive oxygen species (ROS) in cancer cells is associated with cancer development, but the underlying mechanisms and therapeutic significance remain elusive. In this study, we reported that levels of ROS and p22(phox) expression are greatly increased in human prostate cancer tissues, and knockdown of p22(phox) by specific shRNA decreased ROS levels in prostate cancer cells. We also showed that this shRNA-mediated downregulation of p22(phox) in prostate cancer cells inhibited cell proliferation and colony formation, which was mediated by AKT and ERK1/2 signaling pathways and their downstream molecules HIF-1α and VEGF. The NADPH oxidase subunit NOX1 was also elevated in prostate cancer cells, and was involved in activation of AKT/ERK/HIF-1/VEGF pathway and regulation of cell proliferation. Knockdown of p22(phox) resulted in inhibition of tumor angiogenesis and tumor growth in nude mice. These findings reveal a new function of p22(phox) in tumor angiogenesis and tumor growth, and suggest that p22(phox) is a potential novel target for prostate cancer treatment.